Clough Capital Partners
11
58M
10
6
- Areas of investment
Summary
The main department of described VC is located in the Boston. The company was established in North America in United States.
The common things for fund are deals in the range of 50 - 100 millions dollars. The higher amount of exits for fund were in 2017. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 investment rounds annually. Opposing the other organizations, this Clough Capital Partners works on 54 percentage points more the average amount of lead investments.
The overall number of key employees were 2.
The typical case for the fund is to invest in rounds with 8-9 participants. Despite the Clough Capital Partners, startups are often financed by Kleiner Perkins, DAG Ventures, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Quan Capital, Qiming Venture Partners, OrbiMed. In the next rounds fund is usually obtained by Novartis.
The fund has no exact preference in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the various public portfolio startups of the fund, we may underline ARMO BioSciences, Arcellx, Elcelyx Therapeutics Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Therapeutics, Genetics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 0
- Exits
- 6
- Investments by industry
- Biotechnology (9)
- Health Care (5)
- Therapeutics (4)
- Pharmaceutical (4)
- Medical (3) Show 6 more
- Investments by region
-
- United States (10)
- Peak activity year
- 2017
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 160M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Amunix | 04 Mar 2021 | Biotechnology, Medical, Developer Platform, Therapeutics | Early Stage Venture | 117M | United States, California, Mountain View |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.